Health on MSN2d
What To Know About Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Medically reviewed by Qin Rao, MD Metabolic dysfunction-associated steatohepatitis (MASH)—previously known as nonalcoholic ...
Medindia6d
Asah1 Gene Identified as Potential Target for Treating Liver Disease
About 25% of NAFLD patients progress to a more severe stage including liver inflammation (nonalcoholic steatohepatitis, NASH) and scarring (liver fibrosis), which can lead to cirrhosis or even ...
Taiwan News3d
Shilpa Medicare Secures SEC-CDSCO Nod for Nor-Ursodeoxycholic Acid Tablets, Eyes Market Launch for NASH
Left untreated, NAFLD can progress to non-alcoholic steatohepatitis (NASH), a severe and potentially fatal condition ... Key findings include: Liver Fibrosis Reversal: 83.3% of participants showed ...
CRN4d
AI's Impact On the Channel: CRN In Depth
At CRN parent The Channel Company's Xchange March 2025 event, CRN’s Jennifer Follett and Stuart Sumner discussed Sumner's keynote panel in which he shared new research on AI investment trends.
CRN4d
Prediction Time: 2025 Channel Madness Bracket Contest Is Now Open
Think you can forecast the results of the 2025 CRN Channel Madness Tournament of Chiefs? Voting begins March 13, but you can pick your bracket winners now. Voting in CRN's eleventh annual Channel ...
Nature4d
Non-alcoholic steatohepatitis articles from across Nature Portfolio
Non-alcoholic steatohepatitis (NASH) is a condition characterized by accumulation of fat, inflammation and injury in liver cells in people who consume little or no alcohol. It is the progressive ...
Medscape3d
Nonalcoholic Steatohepatitis: Risk Factors and Diagnosis
NASH diagnostics consists of CK-18 total, CK-18 cleaved, adiponectin and resistin. NASH diagnostic panel consists of diabetes, gender, BMI, triglyceride and CK-18 total, CK-18 cleaved levels.